Tonix Pharmaceuticals Holding Corp. (TNXP)
6.04
-0.38
(-5.92%)
USD |
NASDAQ |
Oct 16, 16:00
6.08
+0.04
(+0.66%)
After-Hours: 20:00
Tonix Pharmaceuticals Net Income (TTM) : -159.67M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -159.67M |
| March 31, 2026 | -147.39M |
| December 31, 2025 | -124.02M |
| September 30, 2025 | -99.22M |
| June 30, 2025 | -81.42M |
| March 31, 2025 | -131.93M |
| December 31, 2024 | -130.04M |
| September 30, 2024 | -135.25M |
| June 30, 2024 | -149.01M |
| March 31, 2024 | -98.59M |
| December 31, 2023 | -116.66M |
| September 30, 2023 | -121.02M |
| June 30, 2023 | -122.02M |
| March 31, 2023 | -116.81M |
| December 31, 2022 | -110.22M |
| September 30, 2022 | -108.09M |
| June 30, 2022 | -97.64M |
| March 31, 2022 | -98.05M |
| December 31, 2021 | -92.29M |
| September 30, 2021 | -79.76M |
| June 30, 2021 | -73.22M |
| March 31, 2021 | -63.84M |
| December 31, 2020 | -50.46M |
| September 30, 2020 | -42.15M |
| June 30, 2020 | -38.00M |
| Date | Value |
|---|---|
| March 31, 2020 | -29.66M |
| December 31, 2019 | -28.62M |
| September 30, 2019 | -27.50M |
| June 30, 2019 | -25.14M |
| March 31, 2019 | -25.39M |
| December 31, 2018 | -26.09M |
| September 30, 2018 | -23.99M |
| June 30, 2018 | -24.30M |
| March 31, 2018 | -22.99M |
| December 31, 2017 | -21.12M |
| September 30, 2017 | -23.11M |
| June 30, 2017 | -24.90M |
| March 31, 2017 | -29.93M |
| December 31, 2016 | -38.84M |
| September 30, 2016 | -44.72M |
| June 30, 2016 | -50.39M |
| March 31, 2016 | -52.35M |
| December 31, 2015 | -48.05M |
| September 30, 2015 | -43.68M |
| June 30, 2015 | -37.85M |
| March 31, 2015 | -32.13M |
| December 31, 2014 | -27.62M |
| September 30, 2014 | -22.33M |
| June 30, 2014 | -18.01M |
| March 31, 2014 | -14.05M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | -67.43M |
| Nektar Therapeutics | -157.13M |
| Heron Therapeutics, Inc. | -34.05M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |